Despite lots of positive vibes among shareholders, I'm not too impressed at all with this and not sure why it is deemed price sensitive. There are so many unknowns stated in this announcement its ridiculous (highlighted in yellow). This trial will take at least 2-3 years to conclude to the primary endpoint from now.
This announcement shows nothing but uncertainty, and it may as well say nothing at all. I'll keep a watch from the sidelines for now but may consider re-entering a position under $1 should it eventuate. Good luck to all holders.
- Forums
- ASX - By Stock
- Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
Despite lots of positive vibes among shareholders, I'm not too...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B |
Open | High | Low | Value | Volume |
$1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 39613 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | 1.565 |
3 | 15000 | 1.560 |
2 | 8950 | 1.545 |
3 | 52000 | 1.540 |
1 | 100000 | 1.525 |
Price($) | Vol. | No. |
---|---|---|
1.570 | 14365 | 2 |
1.580 | 57756 | 6 |
1.585 | 5500 | 1 |
1.590 | 3123 | 1 |
1.600 | 5000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online